- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 339/02 - Cycles à cinq chaînons
Détention brevets de la classe C07D 339/02
Brevets de cette classe: 31
Historique des publications depuis 10 ans
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
3
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Dow AgroSciences LLC | 1214 |
4 |
| Cedars-Sinai Medical Center | 1177 |
4 |
| FUJIFILM Corporation | 29839 |
3 |
| Celltrion Chemical Research Institute | 6 |
2 |
| Celltrion Pharm, Inc. | 8 |
2 |
| Merck & Co., Inc. | 251 |
1 |
| Massachusetts Institute of Technology | 10150 |
1 |
| Sumitomo Chemical Company, Limited | 9109 |
1 |
| The United States of America as represented by the Secretary of the Navy | 2804 |
1 |
| Korea Institute of Science and Technology | 2157 |
1 |
| Bar-Ilan University | 439 |
1 |
| The Catholic University of Korea Industry-academic Cooperation Foundation | 821 |
1 |
| Cellixbio Private Limited | 152 |
1 |
| Encore Health, LLC | 14 |
1 |
| Multi Formulations Ltd. | 13 |
1 |
| National Science and Technology Development Agency | 50 |
1 |
| Rhodia Operations | 1553 |
1 |
| Sulfidris S.r.l. | 3 |
1 |
| The UAB Research Foundation | 651 |
1 |
| Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. | 1348 |
1 |
| Autres propriétaires | 1 |